Growth Factors and Signalling Molecules for Cartilage Tissue Engineering – from Embryology to Innovative Release Strategies for Guided Tissue Engineering

Modern Tissue Engineering represents a highly complex interdisciplinary branch of science which brings the life sciences and engineering together to design innovative solutions for the treatment of critical tissue defects after traumatic or degenerative damage. In this area an interesting evolution can be observed in the approach to achieve this goal: Originally understood as a principally biomaterial-based strategy using natural and synthetic materials as implants to be integrated into the neighbouring tissue, during the last two decades a change of paradigm has taken place which involves a movement away from the structural replacement of damaged tissue towards strategies to regenerate functional tissue (Kirkpatrick et al., 2006). In this approach cells play an important role, for example in seeding scaffold materials, which give a preformed structure for the regenerating tissue. A major aim is the synthesis of so-called tissue-like structures in vitro which can be implanted in the damaged tissue site and should be integrated into the body’s own tissue. Relevant obstacles to this strategy are the proper morphological integration of the cell-material construct in the structural context of the damaged tissue site as well as the maintenance of its function. The use of cells in combination with different biomaterials gives an important

[1]  Helmut Schubert,et al.  Immobilization and controlled release of prostaglandin E2 from poly-L-lactide-co-glycolide microspheres. , 2009, Journal of biomedical materials research. Part A.

[2]  Christoph Brochhausen,et al.  Signalling molecules and growth factors for tissue engineering of cartilage—what can we learn from the growth plate? , 2009, Journal of tissue engineering and regenerative medicine.

[3]  R. Guldberg,et al.  Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4. , 2009, The American journal of pathology.

[4]  S. Gilbert,et al.  Clonal chondroprogenitors maintain telomerase activity and Sox9 expression during extended monolayer culture and retain chondrogenic potential. , 2009, Osteoarthritis and cartilage.

[5]  R. Zehbe,et al.  Stability of prostaglandin E2 (PGE2) embedded in poly-d,l-lactide-co-glycolide microspheres: a pre-conditioning approach for tissue engineering applications , 2009, Journal of materials science. Materials in medicine.

[6]  M. Casal,et al.  Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery) , 2008, Journal of tissue engineering and regenerative medicine.

[7]  Stacey A. Jones Mini-review: endocrine actions of fibroblast growth factor 19. , 2008, Molecular pharmaceutics.

[8]  J. Ringe,et al.  Emulsion-based synthesis of PLGA-microspheres for the in vitro expansion of porcine chondrocytes. , 2007, Biomolecular engineering.

[9]  Helmut Schubert,et al.  Characterization of oriented protein-ceramic and protein-polymer-composites for cartilage tissue engineering using synchrotron μ-CT , 2007 .

[10]  Y. Maeda,et al.  Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone , 2007, Proceedings of the National Academy of Sciences.

[11]  Michael Chau,et al.  Gradients in bone morphogenetic protein-related gene expression across the growth plate. , 2007, The Journal of endocrinology.

[12]  W. Wilcox,et al.  Fibroblast Growth Factors 1, 2, 17, and 19 Are the Predominant FGF Ligands Expressed in Human Fetal Growth Plate Cartilage , 2007, Pediatric Research.

[13]  G. Stein,et al.  HOXA10 Controls Osteoblastogenesis by Directly Activating Bone Regulatory and Phenotypic Genes , 2007, Molecular and Cellular Biology.

[14]  D. Ornitz,et al.  FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. , 2007, Developmental biology.

[15]  R. Behringer,et al.  BMPs regulate multiple aspects of growth-plate chondrogenesis through opposing actions on FGF pathways , 2006, Development.

[16]  C. Kirkpatrick,et al.  Visions for regenerative medicine: interface between scientific fact and science fiction. , 2006, Artificial organs.

[17]  T. Hardingham,et al.  Cartilage, SOX9 and Notch signals in chondrogenesis , 2006, Journal of anatomy.

[18]  C. Kirkpatrick,et al.  Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ – prostaglandin E2 dependent proliferation of growth plate chondrocytes , 2006, Arthritis research & therapy.

[19]  H. Kronenberg PTHrP and Skeletal Development , 2006, Annals of the New York Academy of Sciences.

[20]  Frederic Shapiro,et al.  Bone development: interaction of molecular components and biophysical forces. , 2005, Clinical orthopaedics and related research.

[21]  Di Chen,et al.  Bone Morphogenetic Proteins , 2004, Growth factors.

[22]  J. Baron,et al.  Fundamental limits on longitudinal bone growth: growth plate senescence and epiphyseal fusion , 2004, Trends in Endocrinology & Metabolism.

[23]  R. Zehbe,et al.  Oriented Collagen-Based/Hydroxyapatite Matrices for Articular Cartilage Replacement , 2003 .

[24]  M. Bygdeman Pharmacokinetics of prostaglandins. , 2003, Best practice & research. Clinical obstetrics & gynaecology.

[25]  A. Aszódi,et al.  Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. , 2003, Genes & development.

[26]  T. Kobayashi,et al.  Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. , 2003, Osteoarthritis and cartilage.

[27]  H. Kronenberg,et al.  Developmental regulation of the growth plate , 2003, Nature.

[28]  R. O’Keefe,et al.  The biology of the growth plate. , 2003, The Journal of bone and joint surgery. American volume.

[29]  T. Kirsch,et al.  Annexin-mediated Ca2+ Influx Regulates Growth Plate Chondrocyte Maturation and Apoptosis* , 2003, The Journal of Biological Chemistry.

[30]  Marie-Christine Chaboissier,et al.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. , 2002, Genes & development.

[31]  E Wintermantel,et al.  Resorbable defect analog PLGA scaffolds using CO2 as solvent: structural characterization. , 2002, Journal of biomedical materials research.

[32]  E. Wintermantel,et al.  pH-stabilization of predegraded PDLLA by an admixture of water-soluble sodiumhydrogenphosphate--results of an in vitro- and in vivo-study. , 2002, Biomaterials.

[33]  T. Kirsch,et al.  Retinoic acid stimulates annexin-mediated growth plate chondrocyte mineralization , 2002, The Journal of cell biology.

[34]  F. Glorieux,et al.  Human fetal bone development: histomorphometric evaluation of the proximal femoral metaphysis. , 2002, Bone.

[35]  Ola Nilsson,et al.  The role of the resting zone in growth plate chondrogenesis. , 2002, Endocrinology.

[36]  T. Doetschman,et al.  TGFbeta2 mediates the effects of hedgehog on hypertrophic differentiation and PTHrP expression. , 2002, Development.

[37]  S. Narumiya,et al.  Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Baron,et al.  Catch-Up Growth Is Associated with Delayed Senescence of the Growth Plate in Rabbits , 2001, Pediatric Research.

[39]  N. Kanatani,et al.  Skeletal Malformations Caused by Overexpression of Cbfa1 or Its Dominant Negative Form in Chondrocytes , 2001, The Journal of cell biology.

[40]  Nobuyuki Itoh,et al.  Fibroblast growth factors , 2001, Genome Biology.

[41]  S. Takeda,et al.  Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. , 2001, Genes & development.

[42]  E. Schwarz,et al.  BMP signaling stimulates chondrocyte maturation and the expression of Indian hedgehog , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[43]  H. Nah,et al.  The Roles of Annexins and Types II and X Collagen in Matrix Vesicle-mediated Mineralization of Growth Plate Cartilage* , 2000, The Journal of Biological Chemistry.

[44]  C. Patrick,et al.  Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. , 2000, Journal of biomedical materials research.

[45]  A. Reddi,et al.  Morphogenesis and tissue engineering of bone and cartilage: inductive signals, stem cells, and biomimetic biomaterials. , 2000, Tissue engineering.

[46]  L. Niswander,et al.  BMPs are required at two steps of limb chondrogenesis: formation of prechondrogenic condensations and their differentiation into chondrocytes. , 2000, Developmental biology.

[47]  Yoshiaki Ito Molecular basis of tissue‐specific gene expression mediated by the Runt domain transcription factor PEBP2/CBF , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[48]  H. Burtscher,et al.  The Transcription Factor Sox9 Is Involved in BMP‐2 Signaling , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[50]  M. Boyer,et al.  Transplantation of epiphyseal plate allografts between animals of different ages. , 1999, Journal of pediatric orthopedics.

[51]  Richard R. Behringer,et al.  Sox9 is required for cartilage formation , 1999, Nature Genetics.

[52]  S. Nomura,et al.  Maturational disturbance of chondrocytes in Cbfa1‐deficient mice , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[53]  M. Wegner,et al.  From head to toes: the multiple facets of Sox proteins. , 1999, Nucleic acids research.

[54]  S. Mundlos,et al.  Regulation of chondrocyte differentiation by Cbfa1 , 1999, Mechanisms of Development.

[55]  S. Narumiya,et al.  Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.

[56]  G. Gibson,et al.  Active role of chondrocyte apoptosis in endochondral ossification , 1998, Microscopy research and technique.

[57]  Véronique Lefebvre,et al.  A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.

[58]  J. Isner,et al.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. , 1998, Circulation research.

[59]  Gabriele Bergers,et al.  MMP-9/Gelatinase B Is a Key Regulator of Growth Plate Angiogenesis and Apoptosis of Hypertrophic Chondrocytes , 1998, Cell.

[60]  B. Boyan,et al.  The effect of prostaglandin E2 on costochondral chondrocyte differentiation is mediated by cyclic adenosine 3',5'-monophosphate and protein kinase C. , 1998, Endocrinology.

[61]  B. Crombrugghe,et al.  Toward understanding SOX9 function in chondrocyte differentiation. , 1998 .

[62]  J. Massagué,et al.  Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. , 1997, Genes & development.

[63]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[64]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[65]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[66]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[67]  B. Lanske,et al.  Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. , 1996, Endocrinology.

[68]  P. Benya,et al.  Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers. , 1996, Endocrinology.

[69]  I. Kaitila,et al.  Achondroplasia is defined by recurrent G380R mutations of FGFR3. , 1995, American journal of human genetics.

[70]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[71]  D. Church,et al.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.

[72]  P. Puolakkainen,et al.  Stimulation of bone healing by transforming growth factor-beta 1 released from polymeric or ceramic implants. , 1994, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[73]  M. Hirafuji,et al.  Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1. , 1994, Prostaglandins, leukotrienes, and essential fatty acids.

[74]  H. Seyberth,et al.  Determination of seven prostanoids in 1 ml of urine by gas chromatography-negative ion chemical ionization triple stage quadrupole mass spectrometry. , 1994, Journal of chromatography.

[75]  M. Silbermann,et al.  Chondroclasts and endothelial cells collaborate in the process of cartilage resorption , 1992, The Anatomical record.

[76]  J. Puzas,et al.  Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[77]  G. Breur,et al.  Linear relationship between the volume of hypertrophic chondrocytes and the rate of longitudinal bone growth in growth plates , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[78]  Robin Lovell-Badge,et al.  A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif , 1990, Nature.

[79]  M. Iwamoto,et al.  Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. , 1990, The Journal of biological chemistry.

[80]  E. Hunziker,et al.  Is longitudinal bone growth influenced by diurnal variation in the mitotic activity of chondrocytes of the growth plate? , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[81]  S. Miller,et al.  Local infusion of prostaglandin E1 stimulates mandibular bone formation in vivo. , 1988, Journal of oral pathology.

[82]  M. Urist,et al.  Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. , 1988, Clinical orthopaedics and related research.

[83]  W. L. Davis,et al.  Bovine Bone Morphogenetic Protein (bBMP) Fraction‐induced Repair of Craniotomy Defects in the Rhesus Monkey (Macaca speciosa) , 1987, Clinical orthopaedics and related research.

[84]  K.,et al.  Quantitation of chondrocyte performance in growth-plate cartilage during longitudinal bone growth. , 1987, The Journal of bone and joint surgery. American volume.

[85]  T. Iwaya,et al.  Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. , 1980, The Journal of pediatrics.

[86]  T. M. King,et al.  13, 14-dihydro-15-keto-prostaglandin F2alpha concentrations in human plasma and amniotic fluid. , 1979, American journal of obstetrics and gynecology.

[87]  C. Brighton,et al.  Oxygen tension in zones of the epiphyseal plate, the metaphysis and diaphysis. An in vitro and in vivo study in rats and rabbits. , 1971, The Journal of bone and joint surgery. American volume.

[88]  J TRUETA,et al.  The vascular contribution to osteogenesis. I. Studies by the injection method. , 1960, The Journal of bone and joint surgery. British volume.

[89]  R. Zehbe,et al.  Short-term human chondrocyte culturing on oriented collagen coated gelatine scaffolds for cartilage replacement. , 2005, Bio-medical materials and engineering.

[90]  Rong-Sen Yang,et al.  Increased bone growth by local prostaglandin E2 in rats , 2004, Calcified Tissue International.

[91]  J. Compston,et al.  Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone. , 2001, Bone.

[92]  B. Olsen,et al.  Bone development. , 2000, Annual review of cell and developmental biology.

[93]  R. Cancedda,et al.  Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. , 2000, Journal of cell science.

[94]  M. Weinreb,et al.  Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae. , 1998, The Journal of endocrinology.

[95]  V. Lefebvre,et al.  Toward understanding SOX9 function in chondrocyte differentiation. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[96]  Y. Kuga,et al.  Transcranial Doppler pattern after intracarotid papaverine and prostaglandin E1 incorporated in lipid microsphere in patients with vasospasm. , 1998, Neurologia medico-chirurgica.

[97]  J. Danks,et al.  Distribution and functions of parathyroid hormone-related protein in vertebrate cells. , 1996, International review of cytology.

[98]  C. Dinarello,et al.  Influence of Prostaglandins , 1989 .